[2] Martins F., Santos S., Ventura C., Elvas-Leitao R., Santos L., Vitorino S., Reis M., Miranda V., Correia H.F., Aires-de-Sousa J., Kovalishyn V., Latino D.A.R.S., Ramos J., Viveiros M., Design,
Synthesis and Biological Evaluation of Novel Isoniazid Derivatives with Potent Antitubercular Activity,
Eur. J. Med. Chem. 81: 119-138 (2014).
[3] Xia L., Xia Y.F., Huang L.R., Xiao X., Lou H.Y., Liu T.J., Pan W.D., Luo H.,
Benzaldehyde Schiff Bases Regulation to the Metabolism, Hemolysis,
and Virulence Genes Expression in Vitro and Their Structure–Microbicidal Activity Relationship,
Eur. J. Med. Chem. 97: 83-93 (2015).
[4] Judge V., Narasimhan B., Ahuja M., Sriram D., Yogeeswari P., De Clercq E., Pannecouque C., Balzarini J., Synthesis,
Antimycobacterial, Antiviral, Antimicrobial Activity and QSAR Studies of N2-acyl isonicotinic Acid Hydrazide Derivatives,
Med. Chem. 9: 53-76 (2013).
[6] Dandawate P., Khan E., Padhye S., Gaba H., Sinha S., Deshpande J., Swamy K.V., Khetmalas M., Ahmad A., Sarkar F.H.,
Synthesis, Characterization, Molecular Docking and Cytotoxic Activity of Novel Plumbagin Hydrazones Against Breast Cancer Cells,
Bioorg. Med. Chem. Lett. 22: 3104-3108 (2012).
[12] Salehi M., Ghasemi F., Kubicki M., Asadi A., Behzad M., Ghasemi M.H., Gholizadeh A.,
Synthesis, Characterization, Structural Study and Antibacterial Activity of the Schiff Bases Derived from Sulfanilamides and Related Copper (II) Complexes,
Inorg. Chim. Acta., 453: 238-246 (2016).
[20] Vosatka R., Kratky M., Svarcova M., Janousek J., Stolarikova J., Madacki J., Huszar S., Mikusova K., Kordulakova J., Trejtnar F., Vinsova J.,
New Lipophilic Isoniazid Derivatives and Their 1,3,4-Oxadiazole Analogues: Synthesis, Antimycobacterial Activity and Investigation of Their Mechanism of Action,
Eur. J. Med. Chem. 151: 824-835 (2018).
[22] Jorgensen J.H., Murray P.R., Baro E.J., Pfaller M.A., Tonover R.H., Yoken (Eds.), "Manual of Clinical Microbiology", American Society of Microbiology, Washington, 1275-1414 (1995).